Evidence map›Paper›PMID 33906746›Full record

ArticleAuris, nasus, larynx2022

Development of infectious mononucleosis as an unusual manifestation of COVID-19.

Masatoshi Fukuda, Yuta Amano, Chisako Masumura, Makoto Ogawa, Hidenori Inohara

Abstract readCase Reports
In one paragraph

Article in Auris, nasus, larynx, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Masatoshi FukudaDepartment of Otorhinolaryngology, JCHO Osaka Hospital, Osaka, Japan. Electronic address: mfukuda@ent.med.osaka-u.ac.jp.
Yuta AmanoDepartment of Otorhinolaryngology, JCHO Osaka Hospital, Osaka, Japan.
Chisako MasumuraDepartment of Otorhinolaryngology, JCHO Osaka Hospital, Osaka, Japan.
Makoto OgawaDepartment of Otorhinolaryngology, JCHO Osaka Hospital, Osaka, Japan.
Hidenori InoharaDepartment of Otorhinolaryngology - Head and Neck Surgery, Osaka University Graduate School of Medicine, Suita, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has generally been reported that patients with COVID-19 show a fever, cough, and/or respiratory failure as the most common clinical symptoms but some have unusual symptoms, such as anosmia, diarrhea, and throat pain. We herein report a 26-year-old woman with chief complaints of lymphadenopathy and a fever. First, she underwent a laboratory examination, which showed a high proportion of atypical lymphocytes (19%) and an increase in hepatic enzyme activities, and was then hospitalized with a diagnosis of infectious mononucleosis (IM). However, the blood examination did not show any increase in anti-Epstein-Barr virus VCM-IgM. Subsequently, she developed tonsillar hypertrophy with purulent plugs. An additional examination for infection of other pathogens revealed positivity only for SARS-CoV-2 in a loop-mediated isothermal amplification (LAMP) test. The patient was transferred to the COVID-19-specific isolation ward, and none of the ward staff, patients, or either of the two otolaryngologists who had directly examined this patient showed positive signs for SARS-CoV-2 in a LAMP test. Consequently, this case suggests that even if patients show clinical symptoms and signs of common diseases for otolaryngologists, such as IM, we should keep in mind the possibility of COVID-19 without arbitrarily assuming that IM is caused by Epstein-Barr virus.

Indexed as

COVID-19Infectious MononucleosisPharyngitisAdultFemaleFeverHerpesvirus 4, HumanHumansSARS-CoV-2Atypical lymphocyteCOVID-19Infectious mononucleosisLiver dysfunctionSplenomegaly

Identifiers

PMID33906746
PMCPMC8041235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.